| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
2.85 0.17 (0.06%) |
11-16 16:00 |
|
Open: |
2.71 |
Pre close: |
2.68 |
Target:
|
4.31
|
|
High: |
2.91 |
Low: |
2.61 |
Resistance:
|
3.69
4.45
|
|
Volume: |
99,865 |
Market Cap: |
65M |
Support:
|
2.46
2.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.03
 |
MACD |
MACD(12,26):
|
-0.34 |
|
MA(20): |
3.36 |
Signal(12,26,9): |
-0.31 |
|
MA(100): |
4.60 |
Stochastic Oscillator |
%K(14,3):
|
21.31 |
|
MA(250): |
4.25 |
%D(3): |
25.58 |
|
Average Volume(K) |
3-Month: |
8611
|
52-Week |
High:
|
6.35 |
|
10-Days: |
7612 |
Low: |
2.46 |
|
RSI |
RSI(14):
|
33.40  |
Change(%): |
0.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.070 |
Return on Equity (ttm) |
2.1 |
Shares Out. (M) |
22.67 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
1.3 |
Shares Float (M) |
21.01 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.30 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
93.6 |
% Held by Institutions |
53.90 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
0.190 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.440 |
EBITDA (p.s.) |
-0.420 |
P/E |
-2.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-50.02 |
P/S |
71788328.00 |
|
Operating Margin |
-267.08 |
Levered Free Cash Flow
(M) |
-30.04 |
P/CF |
-1.29 |
|
|
|
|
|
|
